Chronic oral endothelin type A receptor antagonism in experimental heart failure.
about
Hepatic and Plasma Endothelin-1 in Dogs with Chronic HepatitisEndothelin receptor antagonists and cardiovascular diseases of aging.Tezosentan in the treatment of acute heart failure.Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.The potential of endothelin antagonism as a therapeutic approach.Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer.Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure.Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans.Hemodynamic, renal, and endocrine responses to acute ET(A) blockade at different ANG II plasma levels.A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes.Pathophysiological plasma ET-1 levels antagonize beta-adrenergic dilation of coronary resistance vessels in conscious dogs.Differential inhibition by the Rho kinase inhibitor Y-27632 of the increases in contractility and Ca2+ transients induced by endothelin-1 in rabbit ventricular myocytes.The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes--possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy.Blockade of Endothelin-1 Receptor Type B Ameliorates Glucose Intolerance and Insulin Resistance in a Mouse Model of Obstructive Sleep Apnea.
P2860
Q33698521-1A7AD39D-22EA-43F7-B852-298C1401654BQ34289891-EB8ECCC7-F58C-4A4D-ADAF-71138DA496C2Q35590982-D1D48C12-D4A3-4E87-AF87-3813261C1074Q35631333-D7BADEFA-BAD0-4FEA-AE9A-9FE94432E1A4Q35925573-2E8E8466-C425-4019-8E41-DF13074AB4DDQ36610315-DEC78ECA-028E-46F3-B7C0-4D653CE427F1Q38695069-0F6251F9-FA8C-4366-8894-DBA5E854B4D9Q41613434-18804B55-BAA5-4F9E-9911-173F4B20358AQ43569460-8A851D31-6AEC-4AF7-B0EC-12CCADFD96E9Q43569485-6DF60A14-6D0E-427C-9CAF-C18A7FC28DE6Q44942590-95D2EFBE-6AE3-4ADE-914A-6679108CF0D5Q46496286-11C29025-67B8-4ACC-8CCD-67F3E41F3EC2Q48175628-1217D3E7-1B58-42A9-A264-12A31967F841Q55346247-0130A947-660C-4AD6-A909-48F5E2ED18FB
P2860
Chronic oral endothelin type A receptor antagonism in experimental heart failure.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Chronic oral endothelin type A receptor antagonism in experimental heart failure.
@en
type
label
Chronic oral endothelin type A receptor antagonism in experimental heart failure.
@en
prefLabel
Chronic oral endothelin type A receptor antagonism in experimental heart failure.
@en
P2093
P356
P1433
P1476
Chronic oral endothelin type A receptor antagonism in experimental heart failure.
@en
P2093
D D Borgeson
E E Williamson
J A Grantham
J C Burnett
M M Redfield
T J Opgenorth
P304
P356
10.1161/01.HYP.31.3.766
P407
P577
1998-03-01T00:00:00Z